Description

Elicvis (apixaban) Coated Tablets 5 mg. №60

Ingredients

Each coated tablet contains 5 mg of apixaban.

Dosage

The recommended dosage of Elicvis (apixaban) is one 5 mg tablet taken orally twice daily.

Indications

Elicvis (apixaban) is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation.

Contraindications

Do not use Elicvis (apixaban) in patients with artificial heart valves or with a history of hypersensitivity to the drug.

Directions

Take Elicvis (apixaban) exactly as prescribed by your healthcare provider. Do not discontinue the medication without consulting your doctor.

Scientific Evidence

Elicvis (apixaban) has been extensively studied in clinical trials for its efficacy and safety in preventing stroke and systemic embolism in patients with atrial fibrillation. Research has shown that apixaban significantly reduces the risk of stroke compared to warfarin, with a lower risk of major bleeding events.

Additional Information

It is important to follow your healthcare provider’s instructions carefully when taking Elicvis (apixaban) to ensure optimal treatment outcomes. Inform your doctor about all medications you are currently taking to avoid potential drug interactions.

Consult your healthcare provider if you experience any unusual bleeding, bruising, or signs of thrombosis while taking Elicvis (apixaban). Regular monitoring and follow-up appointments are essential for the safe and effective use of this medication.